Enhanced Combined 177Lu-DOTATATE and 90Y-DOTATATE Treatment of Patients with Metastatic Neuroendocrine Tumors Refractory to Conventional Therapy: An Ongoing Study. Abstract #358

Abstract content not available

Don’t be disappointed – you can look forward to seeing the full abstract from 10 March 2020 onwards.

Further abstracts you may be interested in

No result